Inhibitors of blood coagulation factor XIII

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11472838
APP PUB NO 20210147478A1
SERIAL NO

17047704

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a compound of general formula (I) as novel inhibitor of blood coagulation factor XIII, methods for synthesis thereof and to use thereof for the prophylaxis or treatment of diseases associated with blood coagulation factor XIII.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZEDIRA GMBH64293 DARMSTADT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Büchold, Christian Karben, DE 6 6
Hils, Martin Darmstadt, DE 11 27
Pasternack, Ralf Griesheim, DE 17 77

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 18, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 18, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 18, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00